ARTICLE | Company News
Sonus terminates Synt:em acquisition
March 16, 2005 2:54 AM UTC
SNUS terminated its previously proposed stock acquisition of Synt:em (Nimes, France). SNUS said it wants to focus on its Tocosol Paclitaxel, which is expected to start Phase III testing in the third quarter. ...